ArticleBiotechnology journal2026
Adaptive Evolution Identifies MHY1-Mediated Transcriptional Reprogramming for Polyphenol Tolerance in Yarrowia lipolytica.
Article in Biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Polyphenols are bioactive compounds used in food, beverages, cosmetics, and medicine. Despite their expanding use, the mechanisms of polyphenol toxicity in microbial polyphenol producers and the adaptive strategies that confer tolerance, remain poorly characterized. Here, we applied adaptive laboratory evolution to evolve tolerance to three structurally distinct polyphenols, curcumin, naringenin, and resveratrol in Yarrowia lipolytica. Whole-genome resequencing of tolerant strains revealed recurrent loss-of-function mutations in the morphogenetic transcription factor MHY1 (YALI1_B28150g) and large segmental duplications on chromosome E, indicating multiple evolutionary solutions. Notably, resveratrol-evolved strains showed strong tolerance in the absence of MHY1 mutations, instead relying on chromosome-scale copy-number variation, highlighting compound-specific adaptive routes. Functional reconstruction demonstrated that MHY1 inactivation is sufficient to confer high-level tolerance, as both gene deletion (ΔMHY1) and independent point mutations (F240L, C153*) reproduce the tolerant phenotype across polyphenols. Transcriptomic analysis showed that MHY1 inactivation is associated with a distinct regulatory state characterized by reduced transcriptional representation of stress-associated pathways and relative stabilization of core metabolic functions. Together, these results identify MHY1 loss-of-function as a dominant and transferable regulatory mechanism for polyphenol tolerance, while also revealing alternative genome-level adaptations selected under severe chemical stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.